IRV Exhaust and Vacuum Pump Replacement
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The U.S. Food and Drug Administration’s Office of Acquisitions and Grants Services is soliciting bids for the IRV Lab Exhaust and Vacuum Pump Replacement Project at the Pacific Southwest Laboratory in Irvine, California, under solicitation number 75F40126R00049. This is a full and open competition requiring contractors to supply all labor, materials, equipment, supervision, permits, testing, commissioning, and related services necessary to remove the existing laboratory vacuum pump system and install a new exhaust system. The scope includes full integration with the Building Automation System, testing and balancing, commissioning, training, and complete project closeout. A mandatory site visit is scheduled for Wednesday, July 22, 2026, at 8:30 a.m. Pacific Time, and attendance is non-negotiable—proposals from offerors who fail to attend will not be considered. Registration for the site visit must be completed by 12:00 p.m. Pacific Time on Monday, July 20, 2026, with each company limited to three representatives who must present valid government-issued photo IDs and comply with FDA security protocols. All offerors must maintain an active registration in SAM.gov throughout the proposal submission, evaluation, and award phases. The solicitation references multiple attachments detailing the statement of work, technical specifications for Room 2309 exhaust, design documents, pricing schedules, security clearance requirements, past performance questionnaires, and quality assurance templates. The NAICS code for this procurement is 236220, indicating construction of commercial buildings. Proposals are due by 4:00 p.m. Pacific Time on Friday, August 14, 2026. The contracting office is located in Rockville, Maryland, with primary and secondary points of contact listed for inquiries. No set-aside applies, and the estimated contract value is not disclosed.
General Info
Agency
NAICS
Place of Performance
Irvine, CA, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Amendment 0001 is issued to provide the Government's responses to questions received regarding the solicitation and to incorporate revisions to the applicable solicitation documents.
Offerors are to review Amendment 0001 and all revised attachments/documents in their entirety and acknowledge receipt of the amendment in accordance with the solicitation instructions.
The proposal due date is extended. Proposal Due Date: August 20, 2026, at 12:00 PM Eastern Time (ET)
******************************************************
The Mandatory Site Visit Attendee List is posted. Please refer to "75F40126R00049 Site Visit Attendee List 260722".
******************************************************
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing Solicitation 75F40126R00049 for the IRV Lab Exhaust & Vacuum Pump Replacement Project at the FDA Pacific Southwest Laboratory, 19701 Fairchild Road, Irvine, California.
This is a full and open competition.
The contractor shall provide all labor, materials, equipment, supervision, permits, testing, commissioning, and related services needed to remove and replace the laboratory vacuum pump system and install a new laboratory exhaust system. The work also includes Building Automation System (BAS) integration, testing and balancing (TAB), commissioning, training, and project closeout, as described in the solicitation and Scope of Work.
Mandatory Site Visit: A mandatory site visit will be held on:
Date: Wednesday, July 22, 2026
Time: 8:30 a.m. Pacific Time
Location: FDA Pacific Southwest Laboratory, 19701 Fairchild Road, Irvine, CA 92612
To attend, offerors must register by 12:00 p.m. Pacific Time on Monday, July 20, 2026 by emailing the Contracting Officer and Contract Specialist listed in the solicitation. Include the names of all attendees when registering. Each company may send up to three (3) representatives. All attendees must present a valid government-issued photo ID and comply with FDA security requirements. Attendance at the site visit is required. The Government will not consider proposals from offerors that do not attend the mandatory site visit. No exceptions.
Submit questions and proposals by the deadlines shown in the solicitation. The solicitation, attachments, and any amendments are available through this SAM.gov notice.
Offerors must have an active registration in SAM.gov when they submit a proposal, during the evaluation period, and before contract award.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency